LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases.
Li Z, Gao J, Sun D, Jiao Q, Ma J, Cui W, Lou Y, Xu F, Li S, Li H.
Li Z, et al. Among authors: li s, li h.
Front Pharmacol. 2022 Nov 29;13:1045501. doi: 10.3389/fphar.2022.1045501. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36523500
Free PMC article.
Review.